Financial results for the period ended December 31, 2025
As filed · Syngene International Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
What happened
FactSyngene International Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. held today, has inter-alia, considered and approved the Un-audited financial results (standalone and. A copy of the unaudited financial results along with the Limited Review Reports.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
RevisedQ4 growth was broad based across research, development and manufacturing services, underpinning full year growth of 4% on a reported basis and 2% in constant currency.
Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- Looking at the year ahead, while the wider global market dynamics remain uncertain, we expect the business mom (management committed by FY26)
- We are maintaining our annual guidance for revenue for FY26. (management committed by FY26)
Evidence
- Syngene International Limited has informed the Exchange regarding Board meeting held on January 22, 2026.(opens the original filing in a new tab)
- Earlier statement · Q4 FY25
- Latest statement · Q4 FY25
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%